Company intelligence / Profile preview

Spineology

Saint Paul / St. Paul Park / Oakdale area*, Minnesota, United Statesspineology.com ↗

Overview

Spineology’s flagship product OptiMesh has demonstrated strong clinical results:

98% fusion at 12 months post-op (IDE trial)
Average of 67% reduction in back pain at three months post-op
Over 50,000 devices implanted to date
Supported by more than twenty years of clinical experience and over twenty peer-reviewed publications[2].

1 asset

Commercial

No major pharma/biotech partnerships disclosed; recent investors include SV Health Investors, RC Capital, and 1315 Capital

Beyond the preview

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Follow clinical development from trial design and recruitment through results.

Explore licensing agreements, acquisitions, and the assets behind each deal.

Trace financing activity and the investors behind a company’s development.

Compare peer pipelines by target, modality, and therapeutic area.

Explore technology platforms and the patent landscape around relevant assets.

Connect company news and source material to the questions you’re investigating.

See how Gosset can support your research on Spineology.